Basic and Clinical Science

Resource
August 11, 2015

Starting antiretroviral therapy (ART) significantly reduces the risk of tuberculosis (TB) for patients in South Africa, investigators report in the online edition of AIDS.

Resource
July 22, 2015

Final follow up of the HPTN 052 study of treatment as prevention shows no evidence of HIV transmission from people with fully suppressed viral load to their partners, four years after the first results from the study demonstrated that early HIV treatment reduced the risk of HIV transmission by 96

Resource
July 7, 2015

To estimate the potential reduction in HIV incidence, we constructed a risk equation based on a flow diagram of the HIV cascade, linking HIV diagnosis and treatment coverage with estimates of annual incidence and prevalence. This was applied to numerous settings.

Resource
July 1, 2015

Efavirenz has become one of the most commonly used antiretroviral agents worldwide and is a component of WHO's recommended first-line antiretroviral therapy regimen.

Resource
May 29, 2015

Objective: Initiation of antiretroviral therapy (ART) during tuberculosis (TB) treatment improves survival in TB-HIV co-infected patients. In patients with CD4+ counts 50cells/mm3.

Resource
May 26, 2015

Antiretroviral therapy (ART) is the most effective preventive strategy against tuberculosis in people with HIV, substantially reducing the risk irrespective of baseline CD4 cell count, tuberculin skin test status, and antimycobacterial drug resistance.

Resource
May 4, 2015

This is an updated introductory two-page document that defines AIDS vaccines and reviews key developments in the field.

Resource
April 22, 2015

Tanzania’s strategic AIDS plan recognizes the impact of the country’s epidemic on people who inject drugs, as well as on other criminalized populations, including men who have sex with men, and people involved in sex work.